vs
Encompass Health Corp（EHC）与盖茨工业（GTES）财务数据对比。点击上方公司名可切换其他公司
Encompass Health Corp的季度营收约是盖茨工业的1.8倍（$1.5B vs $856.2M），Encompass Health Corp净利率更高（9.5% vs 6.0%，领先3.5%），Encompass Health Corp同比增速更快（9.9% vs 3.2%），盖茨工业自由现金流更多（$251.0M vs $116.7M），过去两年Encompass Health Corp的营收复合增速更高（8.3% vs -0.4%）
Encompass Health Corp前身为Amcare及HealthSouth，总部位于美国阿拉巴马州伯明翰，是美国规模最大的住院康复服务提供商，在39个州及波多黎各拥有173家住院康复医院，为中风、神经系统疾病、心肺病症、脑损伤等患者提供专业康复诊疗服务。
盖茨工业总部位于美国科罗拉多州丹佛市，是动力传动带及流体动力产品的专业制造商，产品广泛应用于各类工业和汽车领域。公司员工规模超1.5万人，在美洲、欧洲、亚洲、澳洲及中东均设有销售和生产基地。
EHC vs GTES — 直观对比
营收规模更大
EHC
是对方的1.8倍
$856.2M
营收增速更快
EHC
高出6.7%
3.2%
净利率更高
EHC
高出3.5%
6.0%
自由现金流更多
GTES
多$134.3M
$116.7M
两年增速更快
EHC
近两年复合增速
-0.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $856.2M |
| 净利润 | $146.1M | $51.3M |
| 毛利率 | — | 38.0% |
| 营业利润率 | 16.7% | 12.8% |
| 净利率 | 9.5% | 6.0% |
| 营收同比 | 9.9% | 3.2% |
| 净利润同比 | 20.8% | 40.2% |
| 每股收益（稀释后） | $1.43 | $0.19 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EHCGTES
| Q4 25 | $1.5B | $856.2M | ||
| Q3 25 | $1.5B | $855.7M | ||
| Q2 25 | $1.5B | $883.7M | ||
| Q1 25 | $1.5B | $847.6M | ||
| Q4 24 | $1.4B | $829.4M | ||
| Q3 24 | $1.4B | $830.7M | ||
| Q2 24 | $1.3B | $885.5M | ||
| Q1 24 | $1.3B | $862.6M |
净利润EHCGTES
| Q4 25 | $146.1M | $51.3M | ||
| Q3 25 | $126.5M | $81.6M | ||
| Q2 25 | $142.1M | $56.5M | ||
| Q1 25 | $151.5M | $62.0M | ||
| Q4 24 | $120.9M | $36.6M | ||
| Q3 24 | $108.2M | $47.6M | ||
| Q2 24 | $114.1M | $70.7M | ||
| Q1 24 | $112.5M | $40.0M |
毛利率EHCGTES
| Q4 25 | — | 38.0% | ||
| Q3 25 | — | 39.9% | ||
| Q2 25 | — | 40.8% | ||
| Q1 25 | — | 40.7% | ||
| Q4 24 | — | 40.4% | ||
| Q3 24 | — | 40.4% | ||
| Q2 24 | — | 40.4% | ||
| Q1 24 | — | 38.3% |
营业利润率EHCGTES
| Q4 25 | 16.7% | 12.8% | ||
| Q3 25 | 14.9% | 13.5% | ||
| Q2 25 | 16.2% | 13.1% | ||
| Q1 25 | 16.4% | 14.7% | ||
| Q4 24 | 14.3% | 13.6% | ||
| Q3 24 | 13.6% | 13.6% | ||
| Q2 24 | 14.3% | 15.4% | ||
| Q1 24 | 13.6% | 13.5% |
净利率EHCGTES
| Q4 25 | 9.5% | 6.0% | ||
| Q3 25 | 8.6% | 9.5% | ||
| Q2 25 | 9.7% | 6.4% | ||
| Q1 25 | 10.4% | 7.3% | ||
| Q4 24 | 8.6% | 4.4% | ||
| Q3 24 | 8.0% | 5.7% | ||
| Q2 24 | 8.8% | 8.0% | ||
| Q1 24 | 8.5% | 4.6% |
每股收益（稀释后）EHCGTES
| Q4 25 | $1.43 | $0.19 | ||
| Q3 25 | $1.24 | $0.31 | ||
| Q2 25 | $1.39 | $0.22 | ||
| Q1 25 | $1.48 | $0.24 | ||
| Q4 24 | $1.18 | $0.15 | ||
| Q3 24 | $1.06 | $0.18 | ||
| Q2 24 | $1.12 | $0.26 | ||
| Q1 24 | $1.10 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.2M | $812.1M |
| 总债务越低越好 | $2.4B | $2.2B |
| 股东权益账面价值 | $2.4B | $3.3B |
| 总资产 | $7.1B | $7.2B |
| 负债/权益比越低杠杆越低 | 1.00× | 0.67× |
8季度趋势，按日历期对齐
现金及短期投资EHCGTES
| Q4 25 | $72.2M | $812.1M | ||
| Q3 25 | $48.7M | $689.4M | ||
| Q2 25 | $99.1M | $719.7M | ||
| Q1 25 | $95.8M | $640.2M | ||
| Q4 24 | $85.4M | $682.0M | ||
| Q3 24 | $147.8M | $574.4M | ||
| Q2 24 | $154.4M | $579.7M | ||
| Q1 24 | $134.4M | $522.2M |
总债务EHCGTES
| Q4 25 | $2.4B | $2.2B | ||
| Q3 25 | $2.4B | $2.2B | ||
| Q2 25 | $2.3B | $2.3B | ||
| Q1 25 | $2.3B | $2.3B | ||
| Q4 24 | $2.4B | $2.4B | ||
| Q3 24 | $2.3B | $2.4B | ||
| Q2 24 | $2.7B | $2.3B | ||
| Q1 24 | $2.7B | $2.3B |
股东权益EHCGTES
| Q4 25 | $2.4B | $3.3B | ||
| Q3 25 | $2.4B | $3.4B | ||
| Q2 25 | $2.3B | $3.3B | ||
| Q1 25 | $2.2B | $3.1B | ||
| Q4 24 | $2.1B | $3.0B | ||
| Q3 24 | $2.0B | $3.1B | ||
| Q2 24 | $1.8B | $3.2B | ||
| Q1 24 | $1.7B | $3.2B |
总资产EHCGTES
| Q4 25 | $7.1B | $7.2B | ||
| Q3 25 | $6.9B | $7.1B | ||
| Q2 25 | $6.8B | $7.2B | ||
| Q1 25 | $6.6B | $6.9B | ||
| Q4 24 | $6.5B | $6.8B | ||
| Q3 24 | $6.5B | $7.1B | ||
| Q2 24 | $6.4B | $7.0B | ||
| Q1 24 | $6.2B | $7.0B |
负债/权益比EHCGTES
| Q4 25 | 1.00× | 0.67× | ||
| Q3 25 | 1.01× | 0.66× | ||
| Q2 25 | 1.02× | 0.72× | ||
| Q1 25 | 1.08× | 0.75× | ||
| Q4 24 | 1.14× | 0.78× | ||
| Q3 24 | 1.20× | 0.76× | ||
| Q2 24 | 1.46× | 0.73× | ||
| Q1 24 | 1.54× | 0.74× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $346.0M | $269.8M |
| 自由现金流经营现金流 - 资本支出 | $116.7M | $251.0M |
| 自由现金流率自由现金流/营收 | 7.6% | 29.3% |
| 资本支出强度资本支出/营收 | 14.8% | 2.2% |
| 现金转化率经营现金流/净利润 | 2.37× | 5.26× |
| 过去12个月自由现金流最近4个季度 | $439.2M | $404.9M |
8季度趋势，按日历期对齐
经营现金流EHCGTES
| Q4 25 | $346.0M | $269.8M | ||
| Q3 25 | $270.8M | $98.0M | ||
| Q2 25 | $270.2M | $103.0M | ||
| Q1 25 | $288.6M | $7.3M | ||
| Q4 24 | $278.8M | $190.9M | ||
| Q3 24 | $267.8M | $115.9M | ||
| Q2 24 | $217.4M | $93.8M | ||
| Q1 24 | $238.8M | $-21.0M |
自由现金流EHCGTES
| Q4 25 | $116.7M | $251.0M | ||
| Q3 25 | $83.7M | $80.5M | ||
| Q2 25 | $113.3M | $83.6M | ||
| Q1 25 | $125.5M | $-10.2M | ||
| Q4 24 | $80.1M | $167.6M | ||
| Q3 24 | $120.3M | $94.0M | ||
| Q2 24 | $60.5M | $71.9M | ||
| Q1 24 | $99.4M | $-37.0M |
自由现金流率EHCGTES
| Q4 25 | 7.6% | 29.3% | ||
| Q3 25 | 5.7% | 9.4% | ||
| Q2 25 | 7.8% | 9.5% | ||
| Q1 25 | 8.6% | -1.2% | ||
| Q4 24 | 5.7% | 20.2% | ||
| Q3 24 | 8.9% | 11.3% | ||
| Q2 24 | 4.6% | 8.1% | ||
| Q1 24 | 7.6% | -4.3% |
资本支出强度EHCGTES
| Q4 25 | 14.8% | 2.2% | ||
| Q3 25 | 12.7% | 2.0% | ||
| Q2 25 | 10.8% | 2.2% | ||
| Q1 25 | 11.2% | 2.1% | ||
| Q4 24 | 14.1% | 2.8% | ||
| Q3 24 | 10.9% | 2.6% | ||
| Q2 24 | 12.1% | 2.5% | ||
| Q1 24 | 10.6% | 1.9% |
现金转化率EHCGTES
| Q4 25 | 2.37× | 5.26× | ||
| Q3 25 | 2.14× | 1.20× | ||
| Q2 25 | 1.90× | 1.82× | ||
| Q1 25 | 1.90× | 0.12× | ||
| Q4 24 | 2.31× | 5.22× | ||
| Q3 24 | 2.48× | 2.43× | ||
| Q2 24 | 1.91× | 1.33× | ||
| Q1 24 | 2.12× | -0.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
GTES
| Power Transmission Segment | $536.5M | 63% |
| Fluid Power Segment | $319.7M | 37% |
